Letter to Robert Califf, Commissioner of the Food and Drug Administration - Wyden, Colleagues Renew Request for FDA to Address Concerns about Dangerous Pulse Oximeter Inaccuracies Affecting Communities of Color
Press Release
Date: Aug. 12, 2022
Location: Washington, DC
Issues: Health and Health Care